Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina

American Journal of Infection Control

Volumn 31, Issue 7, 2003, Pages 405-409

  Rosenthal, Victor Daniel ^a,d   Guzman, Sandra ^a   Pezzotto, Stella Maris ^b   Crnich, Christopher J ^c  

^a Hospital Epidemiology   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARGENTINA; ARTICLE; CATHETER INFECTION; CONTROLLED STUDY; EDUCATION PROGRAM; FEMALE; HEALTH EDUCATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MENTAL COMPLIANCE; PRACTICE GUIDELINE; VASCULAR ACCESS;

EID: 0242440171     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2003.52     Document Type: Article

References (22)

1. Crnich CJ, Maki DG. The role of intravascular devices in sepsis. Curr Infect Dis Rep 2001;3:496-506.
2. Maki DG. Risk factors for nosocomial infection in intensive care: 'devices vs nature' and goals for the next decade. Arch Intern Med 1989;149:30-5.
3. Safdar N, Crnich CJ, Maki DG. Nosocomial infections in the intensive care unit associated with invasive medical devices. Curr Infect Dis Rep 2001;3:487-95.
4. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection: I, pathogenesis and short-term devices. Clin Infect Dis 2002;34:1232-42.
5. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-30.
6. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976-81.
7. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-601.
8. Collignon PJ. Intravascular catheter associated sepsis: a common problem, the Australian study on intravascular catheter associated sepsis. Med J Aust 1994;161:374-8.
9. Pearson ML. Guideline for prevention of intravascular device-related infections: part I, intravascular device-related infections, an overview; the hospital infection control practices advisory committee. Am J Infect Control 1996;24:262-77.
10. Scheckler WE, Brimhall D, Buck AS, Farr BM, Friedman C, Garibaldi RA, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report; society for healthcare epidemiology of America. Infect Control Hosp Epidemiol 1998;19:114-24.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
12. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977;296:1305-9.
13. Villanova P. National Committee for Clinical Laboratory Standards (NCCLS). Minimum inhibitory concentration interpretive standards. M7-A4. Vol. Document 2. Washington, DC: National Committee for Clinical Laboratory Standards; 1997.
14. Balows A, Hausler W, Shadomy H. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology; 1991.
15. Gaynes RP, Culver DH, Emori TG, Horan TC, Banerjee SN, Edwards JR, et al. The national nosocomial infections surveillance system: plans for the 1990s and beyond. Am J Med 1991;91:116-20S.
16. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
17. Maki D, Mermel L. Infections due to infusion therapy. In: Bennett JV, Brachman PS. Hospital infections. 4th ed. Philadelphia: Lippincott-Raven; 1998. p. 689-724.
18. Rosenthal VD, Bedoya M, Migone O, Guzman S. Evaluación de los costos especificos de infecciones intra-hospitalarias en areas de cuidados intensivos en un sanatorio privado. X Congreso Chileno De Infecciones Intrahospitalarias Y Epidemiologia Hospitalaria. Concepcion, Chile; 2001.
19. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-8.
20. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-43.
21. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257-66.
22. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial; the Texas medical center catheter study group. Ann Intern Med 1997;127:267-74.